Dr Matthew Stopford

I am currently a post-doctoral research associate working in collaboration with BenevolentAI, a biotechnology company based in London. BenevolentAI have created an artificial intelligence system to identify new therapeutic drugs for ALS, and I am testing their drug candidates in biological models of ALS.


%d bloggers like this: